Akaza's OpenClinica open-source software hits 10K

Akaza Research reports that its OpenClinica open-source software has hit the 10,000 individual-member milestone. That's a three-fold increase in two years. Users hail from 70 countries on six continents.

The open-source development model, despite its provision of free software, accessible source code and a highly accessible user community, remains a minority player among electronic data capture and clinical trial management systems--even though system cost ranks at or near the top of purchase influencers among clinical solutions purchasers.

Akaza sells a commercial-grade, fully supported enterprise edition of OpenClinica in addition to the free community edition. They are in use at biopharma and medical device companies, CROs, and academic centers the company says.